Expression of β-1,4-galactosyltransferase and suppression of β- N-acetylglucosaminidase to aid synthesis of complex N-glycans in insect Drosophila S2 cells
Previously, we have shown that simple paucimannosidic N-glycan structures in insect Drosophila S2 cells arise mainly because of β- N-acetylglucosaminidase (GlcNAcase) action. Thus, in an earlier report, we suppressed GlcNAcase activity and clearly demonstrated that more complex N-glycans with two te...
Saved in:
Published in | Journal of biotechnology Vol. 153; no. 3; pp. 145 - 152 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
20.05.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Previously, we have shown that simple paucimannosidic
N-glycan structures in insect
Drosophila S2 cells arise mainly because of β-
N-acetylglucosaminidase (GlcNAcase) action. Thus, in an earlier report, we suppressed GlcNAcase activity and clearly demonstrated that more complex
N-glycans with two terminal
N-acetylglucosamine (GlcNAc) residues were then synthesized. In the present work, we investigated the synergistic effects of β-1,4-galactosyltransferase (GalT) expression and GlcNAcase suppression on
N-glycan patterns. We found that the
N-glycan pattern of human erythropoietin secreted by engineered S2 cells expressing GalT but not GlcNAcase was complete, even in small portion, except for sialylation; the
N-glycan structures had two terminal galactose (Gal) residues. When GalT was expressed but GlcNAcase was not inhibited,
N-glycan with GlcNAc and Gal at only one branch end was synthesized. Therefore, it will be possible to express a complete functional human glycoprotein in engineered
Drosophila S2 cells by suppressing GlcNAcase and co-expressing additional glycosyltransferases of
N-glycosylation pathway. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.jbiotec.2011.03.021 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2011.03.021 |